These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35171156)
21. Evaluate the Effect of Zinc Oxide and Silver Nanoparticles on Biofilm and icaA Gene Expression in Methicillin-Resistant Staphylococcus aureus Isolated From Burn Wound Infection. Shakerimoghaddam A; Razavi D; Rahvar F; Khurshid M; Ostadkelayeh SM; Esmaeili SA; Khaledi A; Eshraghi M J Burn Care Res; 2020 Nov; 41(6):1253-1259. PubMed ID: 32479611 [TBL] [Abstract][Full Text] [Related]
22. Green synthesis of silver nanoparticles using Carum copticum: Assessment of its quorum sensing and biofilm inhibitory potential against gram negative bacterial pathogens. Qais FA; Shafiq A; Ahmad I; Husain FM; Khan RA; Hassan I Microb Pathog; 2020 Jul; 144():104172. PubMed ID: 32224208 [TBL] [Abstract][Full Text] [Related]
23. Shape-dependent antimicrobial activities of silver nanoparticles. Cheon JY; Kim SJ; Rhee YH; Kwon OH; Park WH Int J Nanomedicine; 2019; 14():2773-2780. PubMed ID: 31118610 [No Abstract] [Full Text] [Related]
24. Antibacterial effects and resistance induction of silver and gold nanoparticles against Staphylococcus aureus-induced mastitis and the potential toxicity in rats. Elbehiry A; Al-Dubaib M; Marzouk E; Moussa I Microbiologyopen; 2019 Apr; 8(4):e00698. PubMed ID: 30079629 [TBL] [Abstract][Full Text] [Related]
25. Silver nanoparticles: Antimicrobial activity, cytotoxicity, and synergism with N-acetyl cysteine. Hamed S; Emara M; Shawky RM; El-Domany RA; Youssef T J Basic Microbiol; 2017 Aug; 57(8):659-668. PubMed ID: 28543603 [TBL] [Abstract][Full Text] [Related]
26. One-Pot Synthesis of Biocompatible Silver Nanoparticle Composites from Cellulose and Keratin: Characterization and Antimicrobial Activity. Tran CD; Prosenc F; Franko M; Benzi G ACS Appl Mater Interfaces; 2016 Dec; 8(50):34791-34801. PubMed ID: 27998108 [TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase. Albiero J; Mazucheli J; Barros JPDR; Szczerepa MMDA; Nishiyama SAB; Carrara-Marroni FE; Sy S; Fidler M; Sy SKB; Tognim MCB Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910903 [TBL] [Abstract][Full Text] [Related]
29. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Fayaz AM; Balaji K; Girilal M; Yadav R; Kalaichelvan PT; Venketesan R Nanomedicine; 2010 Feb; 6(1):103-9. PubMed ID: 19447203 [TBL] [Abstract][Full Text] [Related]
30. Antimicrobial and cytotoxic activity of silver nanoparticles synthesized from two haloalkaliphilic actinobacterial strains alone and in combination with antibiotics. Wypij M; Świecimska M; Czarnecka J; Dahm H; Rai M; Golinska P J Appl Microbiol; 2018 Jun; 124(6):1411-1424. PubMed ID: 29427473 [TBL] [Abstract][Full Text] [Related]
31. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials. Iaconis JP; Pitkin DH; Sheikh W; Nadler HL Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693 [TBL] [Abstract][Full Text] [Related]
32. Silver Nanoparticle-Loaded Titanium-Based Metal-Organic Framework for Promoting Antibacterial Performance by Synergistic Chemical-Photodynamic Therapy. Zhan XP; Zeng YN; Li BX; Zheng HQ; Feng HX; Xu Z; Liu J; Lin ZJ Inorg Chem; 2024 Jan; 63(1):677-688. PubMed ID: 38109074 [TBL] [Abstract][Full Text] [Related]
33. Biosynthesis of Silver Nanoparticles from Shakhatreh MAK; Al-Rawi OF; Swedan SF; Alzoubi KH; Khabour OF; Al-Fandi M Curr Pharm Biotechnol; 2021; 22(9):1254-1263. PubMed ID: 33081683 [TBL] [Abstract][Full Text] [Related]
34. The synergistic effect of using bacteriophages and chitosan nanoparticles against pathogenic bacteria as a novel therapeutic approach. Abdelsattar AS; Yakoup AY; Khaled Y; Safwat A; El-Shibiny A Int J Biol Macromol; 2023 Feb; 228():374-384. PubMed ID: 36581028 [TBL] [Abstract][Full Text] [Related]
35. Chiral Nanoclusters as Alternative Therapeutic Strategies to Confront the Health Threat from Antibiotic-Resistant Pathogens. Wang Z; Tian Y; Hao J; Liu Y; Tang J; Xu Z; Liu Y; Tang B; Huang X; Zhu N; Li Z; Hu L; Li L; Wang Y; Jiang G ACS Nano; 2024 Mar; 18(9):7253-7266. PubMed ID: 38380803 [No Abstract] [Full Text] [Related]
37. Investigation of synergism of meropenem and ciprofloxacin against Pseudomonas aeruginosa and Acinetobacter strains isolated from intensive care unit infections. Ermertcan S; Hoşgör M; Tünger O; Coşar G Scand J Infect Dis; 2001; 33(11):818-21. PubMed ID: 11760161 [TBL] [Abstract][Full Text] [Related]
38. Green Synthesis of Silver Nanoparticles Using Aerial Part Extract of the Ajlouni AW; Hamdan EH; Alshalawi RAE; Shaik MR; Khan M; Kuniyil M; Alwarthan A; Ansari MA; Khan M; Alkhathlan HZ; Shaik JP; Adil SF Molecules; 2022 Dec; 28(1):. PubMed ID: 36615440 [TBL] [Abstract][Full Text] [Related]
39. Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Liao S; Zhang Y; Pan X; Zhu F; Jiang C; Liu Q; Cheng Z; Dai G; Wu G; Wang L; Chen L Int J Nanomedicine; 2019; 14():1469-1487. PubMed ID: 30880959 [TBL] [Abstract][Full Text] [Related]
40. Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers. Pitkin DH; Sheikh W; Nadler HL Clin Infect Dis; 1997 Feb; 24 Suppl 2():S238-48. PubMed ID: 9126699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]